GlassScriptPhysician profile
Bjorn Irion
NPI 1578908273
$1,133.42
in general payments reported to CMS, 2019-2025
11 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.05 · 2021: $24.87 · 2022: $18.78 · 2023: $54.99 · 2024: $834 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $806 · Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $806.28 |
| Food and Beverage | $193.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $806.28 | 2024 | |
| Arthrex, INC. | $90.05 | 2020 | |
| Bioventus LLC | $57.99 | 2021-2025 | Durolane |
| Stryker Corporation | $49.96 | 2025 | Lmh |
| Alliance Medical | $28.92 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $19.73 | 2023 | Iovera |
| Smith+Nephew, INC. | $18.02 | 2023 | Renasys Go V2 Home, Pico 7 |
| Sanofi-Aventis U.S. LLC | $17.24 | 2023 | |
| Organogenesis INC. | $16.38 | 2025 | Via Matrix |
| Vertex Pharmaceuticals Incorporated | $14.67 | 2025 | |
| Ossur Americas, INC. | $14.18 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bjorn Irion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.